Upload
zuzela
View
27
Download
0
Embed Size (px)
DESCRIPTION
Impact of treatment on the natural course of asthma. Prof Dr Elif Dağlı Marmara University Pediatric Pulmonology. What do we expect to change?. What needs to be changed in the naural course? What are the clinical and experimental effects of the drugs? - PowerPoint PPT Presentation
Citation preview
What needs to be changed in the naural course?
What are the clinical and experimental effects of the drugs?
Do the cohort studies reflect the experimental effects?
Why is there a difference between experimental effects of treatment and cohort studies ?
Question 1What needs to be changed in the naural course?
What do we want to prevent?
• Loss of lung fuctions• Remodelling• Inflammation• Asthma attacks• Low quality of life
Natural course of asthma
Initiation and chronicityfactors
Initiation factors
Initiation
Chronicityfactors
Remission factors
Fernando D Martinezwww.thelancet.com Vol 368 , 2006
FD Martinez Lancet , 2006
• Persistent asthma starts early in life
• Children with persistent asthma have low lung functions
• Low lunfctions are settled in early childhood and does not deteroriate further
Remodelling
Normal bronchus Severe asthmaThickened BM
Normal bronchusCollagen stain
Severe asthmaThickened BMCollagen stain
M.L.K. Tang et al. / Pharmacology & Therapeutics 112 (2006) 474–488
Does Remodelling Start before Asthma Symptoms ?
Bronchus of a 4 year old child who died of asthma
PAEDIATRIC RESPIRATORY REVIEWS (2002) 3, 315±320
Does Remodelling Start before Asthma Symptoms ?
• Histological changes in bronchi of children who died of asthma attack, that resembles changes seen in adults
• Bronchial biopsy findings in children who later develop asthma
• Development of remodelling in children who are unresponsive to inhaled steroid treatment
• Correlation of lung functions and remodelling
• Early wheezers should be treated before established asthma symptoms
Pohunek P, Eur Respir J 1997;Martinez FD N Engl J Med 1995; 332: 133±138. Merkus PJFM. Am Rev Respir Dis 1993; 148: 1484±1489. 35 .
Soru 2
What are the clinical and experimental effects of the drugs?
Effects of Inhale steroids on the consequences of asthma
İnhale steroid reduces
BALBronchial mucosaSputum
• Barnes PJ, Adcock IM: Ann Intern Med 2003, 139(5 Pt 1):359-370.
Glococorticoids
INHIBIT
• Barnes PJ, Adcock IM: Ann Intern Med 2003, 139(5 Pt 1):359-370.
glucocortikoids
Barnes PJ, Chung KF, Page CP: Inflammatory mediators of asthma: an update. Pharmacol Rev 1998, 50(4):515-596. 32
Fluticasone
İnhibits• IL-13• IL-5In peripheral blood CD4+ T cell culturesIncreases synthesis of • IL-10
Peek EJ, et al Am J Respir Cell Mol Biol 2005, 33(1):105-111
Beclametasone and Fluticasone
Inhibit• T cell proliferation• IL-5• GM-CSF expression
Powell N, Till SJ, Kay AB, Corrigan CJ: Clin Exp Allergy 2001, 31(1):69-76
Flunisolide
• In cultured sputum cells• Inhibit TGFβ release• Increase MMP-9
(Profita et al., 2004).
Inhaled steroids
Can stop and even reverse structural changes Decreases reticular basal membrane thickness and fibroblast activity.
Hoshino, M.et al. J Allergy Clin Immunol 102, 783–788.
Hoshino, M.,et al . Clin Exp Allergy 28, 568–577.
Hoshino M et al. Clin Rev Allergy Immunol 27, 59–64.
Inhaled steroids inhibits microvascular angiogenic remodelling
• Pla
B N Feltis Thorax 2007;62:314–319.
Placebo
Plasebo
Placebo IKSIKS
IKS
VEGFVEGFRVascular endothelial growth factor inhibition
Inhaled steroids
• Anti-mitogenic for airway smooth muscle • Anti-mitogenic on normal basement
membrane• Can not exhibit the same effect on collagen• Can not be effective after fibrosis
development.
Bonacci, et al Clin Exp Pharmacol Physiol 30, 324–328. Bonacciet al Br J Pharmacol 138, 1203–1206.
Steroids in effective in the presence of collagen
Basal membraneAirway smooth muscle cellsAfter 48 hrs
Collagen depositionAirway smooth muscle cellsAfter 48 hrs
Collagen depositionAirway smooth muscle cellsAfter 7 days
Bonacci JV British Journal of Pharmacology (2006) 149, 365–373.
Inhibits cell proliferation
Ekshale Sistenil Lökotrienler ile Bazal Membran ilişkisi
Lex C et al. Respiratory Research 2006, 7:63
Montelukast (+)
Montelukast (-)
Question 3
Do the cohort studies reflect the experimental effects?
No evidence that inhale steroids reduces asthma at 10 Devulapalli C,Carlsen K et al
0-2 years IKSn=29
0-2 years no IKSn=56
P values Remission at 2 years n=12
Male (%) 58.6 73.2 0.17 91.7
Parental atopy(%)
48.3 35.7 0.23 87.5
Atopic dermatitis at 2 years (%)
48.3 42.9 0.63 41.7
Hospital admissions(%)
65.5 36.4 0.01 -----
No of hospital admissions
1.3 0.5 0.01 ------
Severity score 7.5 4.5 0.01 ---
STARTBusse et al J Allergy Clin Immunol 2008
Budesonide 200 or 400 mcg/day
+regular asthma treatment
Placebo +regular treatment
0 1 2 3 4 5
Double blind phase Open phase
Budesonide 200 or 400 mcg/day
+regular asthma treatment
7241 5-66 aged Mild persistent asthma
(Busse et J Allergy Clin Immunol 2008;121:1167-74.)
In mild persistent asthma early intervention with inhaled budesonide was associated with improved asthma control and less additional asthma medication use.
Question 4
Why is there a difference between experimental effects of treatment and cohort studies ?
Why are cohorts different?
• Early treatment----- how early?• Are the dose and duration of medication
adequate ?• Are all the cohorts have standardised
methods?